Finance

Medivation prices registered direct offering at $16.25 a share to raise about $36 million

Published in Health Business Week, January 12th, 2007

Medivation, Inc. (MDV) announced that it has entered into definitive purchase agreements with institutional investors to sell approximately 2,200,000 shares of its common stock at a price of $16.25 per share in a registered direct offering.

The offering will raise gross proceeds to Medivation of approximately $36 million before placement agent fees and other offering expenses. The sale is being made under Medivation's shelf registration statement declared effective by the Securities and Exchange Commission on November 3, 2006

Cowen and company, LLC was the lead placement agent for this offering. The co-placement agents on the offering were Leerink...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2007-01-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry